Despite the fact that early nonresponse to antipsychotic therapy in patients with schizophrenia is k...

Patients with schizophrenia who receive a long-acting injectable (LAI) formulation as the first anti...

Most individuals with mental illness are not violent, but a study published Wednesday in JAMA Psychi...

Although considerable progress has been made in determining risk factors for psychosis in recent dec...

Psychoeducation appears to improve long-term medication adherence in patients with schizophrenia, le...

A study published in AJP in Advance suggests ABT-126—a selective alpha-7 (α7) nicotinic receptor par...

Analysis of the Recovery After Initial Schizophrenia Episode (RAISE) trial has found that coordinate...

A research team from Broad Institute and Harvard Medical School has identified an immune-system gene...

The development of new technologies to facilitate disease management is a burgeoning field, but expe...